08-05-2025
European Penny Stocks To Consider In May 2025
As European markets show resilience with the pan-European STOXX Europe 600 Index rising by 3.44% amidst easing tariff concerns, investors are increasingly exploring diverse opportunities across the continent. Penny stocks, a term that may seem outdated, continue to capture interest due to their potential for significant value and growth within smaller or less-established companies. By focusing on financial strength and clear growth prospects, these stocks can offer investors a chance to uncover promising opportunities in Europe's evolving market landscape.
Top 10 Penny Stocks In Europe
Name
Share Price
Market Cap
Financial Health Rating
Transferator (NGM:TRAN A)
SEK2.66
SEK263.68M
★★★★★☆
Angler Gaming (NGM:ANGL)
SEK3.75
SEK281.19M
★★★★★★
Hifab Group (OM:HIFA B)
SEK3.48
SEK211.72M
★★★★★★
IMS (WSE:IMS)
PLN3.66
PLN124.05M
★★★★☆☆
AMSC (OB:AMSC)
NOK1.538
NOK110.53M
★★★★★★
Cellularline (BIT:CELL)
€2.58
€54.42M
★★★★★☆
Netgem (ENXTPA:ALNTG)
€0.995
€33.32M
★★★★★★
Fondia Oyj (HLSE:FONDIA)
€4.67
€17.46M
★★★★★★
Mistral Iberia Real Estate SOCIMI (BME:YMIB)
€1.01
€22.01M
★★★★★☆
Deceuninck (ENXTBR:DECB)
€2.13
€294.08M
★★★★★★
Click here to see the full list of 433 stocks from our European Penny Stocks screener.
Let's take a closer look at a couple of our picks from the screened companies.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Valbiotis SA focuses on the research and development of dietary supplements aimed at preventing metabolic and cardiovascular diseases in France, with a market cap of €17.88 million.
Operations: The company generates revenue from its Vitamins & Nutrition Products segment, amounting to €0.18 million.
Market Cap: €17.88M
Valbiotis SA, a pre-revenue biotech company with a market cap of €17.88 million, focuses on dietary supplements for metabolic and cardiovascular disease prevention. Despite having more cash than its total debt and seasoned management, the company faces financial challenges with less than a year of cash runway based on current free cash flow. Recent earnings showed a significant decrease in sales to €0.18 million from the previous year's €4.73 million, alongside an increased net loss of €10.03 million. While trading at 78.6% below estimated fair value, profitability remains elusive over the next three years according to forecasts.
ENXTPA:ALVAL Debt to Equity History and Analysis as at May 2025
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Alpcot Holding AB (publ) operates a digital platform for personal finance in the financial industry in Sweden, with a market cap of approximately SEK144.57 million.
